Clinical Trial Update: Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study [Phase 3]

View source ↗

Summary

Phase 3 trial of anidulafungin for candidemia and invasive candidiasis in intensive care patients completed. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Eraxis (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Invasive Candidiasis | Phase 3 | Status: COMPLETED | Results posted: 2011-05-17